Abstract
Efavirenz (EFA) is an antiviral drug that reduces the progression of HIV infection by reducing the virus's proliferation in the blood. This study used a pencil graphite electrode modified with deoxyribonucleic acid/2-thiobarbituric acid-osmium tetroxide (DNA/TBA-OsO4/PGE) to measure traces of the drug. The electrode surface was modified in two stages by the electrodeposition of thiobarbituric acid-osmium tetroxide and DNA, respectively. Electrode surface characterization was revealed by high-resolution scanning electron microscopy (SEM), electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). Analytical figures of merit, such as the linear range over the concentration range of 1 × 10−12 to 1 × 10−5 M and the detection limit of 1.4 × 10−13 M, demonstrated that the modified DNA/TBA-OsO4/PGE is superior to the other proposed electrodes for the determination of EFA. Additionally, the modified electrode was used to measure EFA in blood, urine and water samples.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have